Ontario Shuts Down Again: Cineplex (TSX:CGX) Stock Plummets

The closure of indoor businesses again will hinder the recovery of movie theatre operations. As a result of Ontario’s shutdown order and release postponement of Hollywood movies, the Cineplex stock is plummeting to all-time lows.

| More on:
crashing stocks

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Canada is entering a dastardly state, as shutdowns return due to the second wave of COVID-19. Ontario ordered the closure of indoor businesses such as bars, restaurants, and theatres again. For Cineplex (TSX:CGX), it’s a tragic development.

After reopening all of its 164 theatres and entertainment venues across the country on August 21, 2020, Cineplex will have to close 28 theatres and three entertainment venues in Ottawa for 28 days in compliance.

The news is scaring investors and sending the stock plummeting. On October 19, 2020, the share price is $4.88 or a year-to-date loss of 86%. Cineplex’s market capitalization is down to $309.06 million.

Positive 2019

If you review last year’s business performance, Cineplex reported total revenue of $1.66 billion and a full-year net income of $28.89 million. The net income was 62% lower than in 2018, as movie theatres lost big time to streaming services. COVID-19 is making it worse for the Box Office segment.

In Q1 and Q2 2020, the company posted a net loss of $178.4 million and $98.9 million, respectively. The quarter’s total revenue ended June 30, 2020, was a measly $22 million, mainly from food services. Also, Cineplex did not receive material cash rent in the second quarter, as the processing of relief measures with landlord partners is ongoing.

Historic unpredictability

Cineplex’s CEO Ellis Jacob admits film exhibitors are facing historic unpredictability during the pandemic. He adds, however, the movie theatre chain is prepared to be “agile and nimble.” Jacob told investors at the company’s webcast that executives are ready to “make the necessary changes required” to push through in the next six to 12 months.

Jacob finds the closure order excessive since management is implementing protocol measures to keep moviegoers safe across Ontario. The teams’ efforts are all for naught. Another hurdle for Cineplex is the constant changing of Hollywood release schedules.

MGM and Eon Productions are pushing back the release of the 25th James Bond movie. Instead of November 2020, the release of No Time To Die starring Daniel Craig will be on April 2, 2021. Even this news sent the stock crashing. Cineplex also filed a lawsuit against the world’s second-biggest cinema operator.

In June 2020, the U.K. movie exhibitor Cineworld Group backed out from a $2.8 billion proposal to acquire Cineplex. The court proceedings will commence next year in September. Cineworld is closing all its theatres in Britain, Ireland, and the U.S.

BMO Capital is downgrading Cineplex’s rating from market perform to underperform. The bank’s analyst Tim Casey cites elevated concerns regarding the COVID-19 pandemic in Canada and Ontario particularly. He adds the release postponements of Hollywood flicks are considerations, because they pose a potential balance sheet risk for Cineplex in 2021.

Dividend Aristocrat no more

The material decreases in revenues prompted management to suspend dividend payments. Cineplex lost its Dividend Aristocrat status in a huff in 2020. It will take a lot more to recover from this limpness. Streaming services have the inside track, given that people are staying home rather than risk infection in enclosed movie theatres.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »